Reporting on Adverse Clinical Events, 2019

DOI: 10.1177/0069477019837708

Keywords: Benzocaine (56),Cannabinoid, Synthetic (62),Capecitabine (68),Cetuximab (63),Chemotherapy (59),Dietary Supplement (64),Diltiazem (57),Febuxostat (79),Fluoxetine (61),Glutathione-L (58),Meropenem (67),Metoprolol (61),Paroxetine (61),Piperacillin/Tazobactam (67),Regorafenib (69),Ticagrelor (66),Topiramate (65),Trazodone (60),Vancomycin (67)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text